Advanced search
Publication Cover
Free Radical Research Volume 54, 2020 - Issue 11-12: SFRR ASIA 2019. Guest Editors: Shinya Toyokuni, Yuji Naito, Koji Uchida
Submit an article Journal homepage
394
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

S-nitrosylated l-serine-modified dendrimer as a kidney-targeting nitric oxide donor for prevention of renal ischaemia/reperfusion injury

Hidemasa Katsumia Department of Biopharmaceutics, Kyoto Pharmaceutical University, Kyoto, JapanCorrespondence[email protected]
View further author information
,
Rie Takashimaa Department of Biopharmaceutics, Kyoto Pharmaceutical University, Kyoto, JapanView further author information
,
Hiroe Suzukia Department of Biopharmaceutics, Kyoto Pharmaceutical University, Kyoto, JapanView further author information
,
Natsuko Hiraia Department of Biopharmaceutics, Kyoto Pharmaceutical University, Kyoto, JapanView further author information
,
Satoru Matsuuraa Department of Biopharmaceutics, Kyoto Pharmaceutical University, Kyoto, JapanView further author information
,
Hiroyuki Kimurab Department of Analytical and Bioinorganic Chemistry, Kyoto Pharmaceutical University, Kyoto, JapanView further author information
,
Masaki Morishitaa Department of Biopharmaceutics, Kyoto Pharmaceutical University, Kyoto, JapanView further author information
&
Akira Yamamotoa Department of Biopharmaceutics, Kyoto Pharmaceutical University, Kyoto, JapanView further author information
 show all
Pages 841-847 | Received 24 Jun 2019, Accepted 20 Nov 2019, Published online: 03 Dec 2019

References

  • Greite R, Thorenz A, Chen R, et al. Renal ischemia-reperfusion injury causes hypertension and renal perfusion impairment in the CD1 mice which promotes progressive renal fibrosis. Am J Physiol Renal Physiol. 2018;314(5):F881–F892.
  • Salvadori M, Rosso G, Bertoni E. Update on ischemia-reperfusion injury in kidney transplantation: pathogenesis and treatment. World J Transplant . 2015;5(2):52–67.
  • Schneider R, Raff U, Vornberger N, et al. L-arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int. 2003;64(1):216–225.
  • Caldwell-Kenkel JC, Currin RT, Tanaka Y, et al. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology. 1989;10(3):292–299.
  • Kanwar S, Tepperman BL, Payne D, et al. Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ Shock. 1994;42(3):135–140.
  • Ignarro LJ, Cirino G, Casini A, et al. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol. 1999;34(6):879–886.
  • Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43(2):109–142.
  • Gholampour H, Moezi L, Shafaroodi H. Aripiprazole prevents renal ischemia/reperfusion injury in rats, probably through nitric oxide involvement. Eur J Pharmacol. 2017;813:17–23.
  • Guan W, Wang Z, Liu Y, et al. Protective effects of tirofiban on ischemia/reperfusion-induced renal injury in vivo and in vitro. Eur J Pharmacol. 2015;761:144–152.
  • Srisawat U, Kongrat S, Muanprasat C, et al. Losartan and sodium nitroprusside effectively protect against renal impairments after ischemia and reperfusion in rats. Biol Pharm Bull. 2015;38(5):753–762.
  • Nilsson KF, Sandin J, Gustafsson LE, et al. The novel nitric oxide donor PDNO attenuates ovine ischemia-reperfusion induced renal failure. Intensive Care Med Exp. 2017;5(1):29.
  • Matsuura S, Katsumi H, Suzuki H, et al. l-serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier. Proc Natl Acad Sci USA. 2018;115(41):10511–10516.
  • Matsuura S, Katsumi H, Suzuki H, et al. l-cysteine and l-serine modified dendrimer with multiple reduced thiols as a kidney-targeting reactive oxygen species scavenger to prevent renal ischemia/reperfusion injury. Pharmaceutics. 2018;10(4):251.
  • Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst. 1958;83(993):670–672.
  • Hnatowich DJ, Layne WW, Childs RL. The preparation and labeling of DTPA-coupled albumin. Int J Appl Radiat Isot. 1982;33(5):327–332.
  • Sharma R, Joubert J, Malan SF. Recent developments in drug design of NO-donor hybrid compounds. Mini Rev Med Chem. 2018;18(14):1175–1198.
  • Richardson G, Benjamin N. Potential therapeutic uses for S-nitrosothiols. Clin Sci (Lond). 2002;102(1):99–105.
  • Katsumi H, Nishikawa M, Yasui H, et al. Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice. J Control Release. 2009;140(1):12–17.
  • Liang M, Knox FG. Production and functional roles of nitric oxide in the proximal tubule. Am J Physiol Regul Integr Comp Physiol. 2000;278(5):R1117–R1124.
  • Rhoden EL, Rhoden CR, Lucas ML, et al. The role of nitric oxide pathway in the renal ischemia-reperfusion injury in rats. Transpl Immunol. 2002;10(4):277–284.
  • Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol. 1996;9(5):836–844.
  • Braverman J, Stanley SA. Nitric oxide modulates macrophage responses to mycobacterium tuberculosis infection through activation of HIF-1α and repression of NF-κB. J Immunol. 2017;199(5):1805–1816.
  • Wright CJ, Agboke F, Chen F, et al. NO inhibits hyperoxia-induced NF-κB activation in neonatal pulmonary microvascular endothelial cells. Pediatr Res. 2010;68(6):484–489.
  • Shunmugavel A, Khan M, Chou PC, et al. Spinal cord injury induced arrest in estrous cycle of rats is ameliorated by S-nitrosoglutathione: novel therapeutic agent to treat amenorrhea. J Sex Med. 2012;9(1):148–158.
  • Katsumi H, Nishikawa M, Yamashita F, et al. Prevention of hepatic ischemia/reperfusion injury by prolonged delivery of nitric oxide to the circulating blood in mice. Transplantation. 2008;85(2):264–269.
  • Ozaki M, Kawashima S, Hirase T, et al. Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle. Am J Pathol. 2002;160(4):1335–1344.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.